- Home
- SLDP vs ALEC Comparison
SLDP vs ALEC Comparison
Compare SLDP & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDP
- ALEC
- Stock Information
- Founded
- SLDP 2011
- ALEC 2013
- Country
- SLDP United States
- ALEC United States
- Employees
- SLDP N/A
- ALEC N/A
- Industry
- SLDP Electrical Products
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SLDP Energy
- ALEC Health Care
- Exchange
- SLDP Nasdaq
- ALEC Nasdaq
- Market Cap
- SLDP 230.9M
- ALEC 232.6M
- IPO Year
- SLDP N/A
- ALEC 2019
- Fundamental
- Price
- SLDP $1.29
- ALEC $1.95
- Analyst Decision
- SLDP Buy
- ALEC Buy
- Analyst Count
- SLDP 4
- ALEC 6
- Target Price
- SLDP $2.75
- ALEC $11.75
- AVG Volume (30 Days)
- SLDP 1.6M
- ALEC 2.0M
- Earning Date
- SLDP 11-07-2024
- ALEC 11-06-2024
- Dividend Yield
- SLDP N/A
- ALEC N/A
- EPS Growth
- SLDP N/A
- ALEC N/A
- EPS
- SLDP N/A
- ALEC N/A
- Revenue
- SLDP $18,026,000.00
- ALEC $61,508,000.00
- Revenue This Year
- SLDP $2.53
- ALEC N/A
- Revenue Next Year
- SLDP $95.43
- ALEC $71.71
- P/E Ratio
- SLDP N/A
- ALEC N/A
- Revenue Growth
- SLDP N/A
- ALEC N/A
- 52 Week Low
- SLDP $1.00
- ALEC $1.85
- 52 Week High
- SLDP $2.35
- ALEC $8.90
- Technical
- Relative Strength Index (RSI)
- SLDP 47.64
- ALEC 26.45
- Support Level
- SLDP $1.05
- ALEC $1.85
- Resistance Level
- SLDP $1.23
- ALEC $2.50
- Average True Range (ATR)
- SLDP 0.05
- ALEC 0.17
- MACD
- SLDP 0.00
- ALEC 0.02
- Stochastic Oscillator
- SLDP 33.33
- ALEC 13.69
About SLDP Solid Power Inc.
Solid Power Inc is engaged in developing all-solid-state battery cell technology to enable the next generation of batteries for the EV and other markets. The company's planned business model is to license its all-solid-state battery cell designs and manufacturing know-how to top tier battery manufacturers or automotive original equipment manufacturers and to sell its sulfide-based solid electrolyte for incorporation into all-solid-state battery cells.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.